Search Results - Rebecca Elstrom

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
    Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma

    Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma by Rebecca Elstrom, John P. Leonard, Morton Coleman, R. K. Brown

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma

    Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma by Jeffrey C. Rathmell, Rebecca Elstrom, Ryan M. Cinalli, Craig B. Thompson

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP‐C) oral combination chemotherapy regimen for recurring/refractory lymphoma: Low‐dose metronomic, multidrug therapy

    Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP‐C) oral combination chemotherapy regimen for recurring/refractory lymphoma: Low‐dose metronomic, multidrug therapy... by Morton Coleman, Peter Martin, Jia Ruan, Richard R. Furman, Rubén Niesvizky, Rebecca Elstrom, M. Patricia George, Thomas Kaufman, John P. Leonard

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration

    Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration by JB Bussel, C. S. Lee, Caroline Seery, Allison Imahiyerobo, Muriel Thompson, Diane Catellier, Ithamar Turenne, Viral Patel, Paul Basciano, Rebecca Elstrom, Waleed Ghanima

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

    Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors by Carrie A. Thompson, MaryE. Charlson, E. Schenkein, Martin T. Wells, Richard R. Furman, Rebecca Elstrom, Jia Ruan, Peter Martin, John P. Leonard

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma

    Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cel... by Jia Ruan, Peter Martin, Morton Coleman, Richard R. Furman, Ken Cheung, Adam S. Faye, Rebecca Elstrom, Mark S. Lachs, Katherine A. Hajjar, John P. Leonard

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    The CD28 Signaling Pathway Regulates Glucose Metabolism

    The CD28 Signaling Pathway Regulates Glucose Metabolism by Kenneth A. Frauwirth, James L. Riley, Marian H. Harris, Richard V. Parry, Jeffrey C. Rathmell, David R. Plas, Rebecca Elstrom, Carl H. June, Craig B. Thompson

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Interim Phase I Clinical Data of FT819-101, a Study of the First-Ever, Off-the-Shelf, iPSC-Derived TCR-Less CD19 CAR T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies

    Interim Phase I Clinical Data of FT819-101, a Study of the First-Ever, Off-the-Shelf, iPSC-Derived TCR-Less CD19 CAR T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Mal... by Amitkumar Mehta, Umar Farooq, Andy Chen, Joseph P. McGuirk, Thomas Ly, Lilly Wong, Sarah Cooley, Bahram Valamehr, Rebecca Elstrom, Yu‐Waye Chu, Jae H. Park

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients

    Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients by Benet Pera, Tiffany Tang, Rossella Marullo, ShaoNing Yang, Haelee Ahn, Jayeshkumar Patel, Rebecca Elstrom, Jia Ruan, Richard R. Furman, John P. Leonard, Leandro Cerchietti, Peter Martin

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Utility of FDG-PET scanning in lymphoma by WHO classification

    Utility of FDG-PET scanning in lymphoma by WHO classification by Rebecca Elstrom, Liang Guan, Gary Baker, Khozaim Nakhoda, Jo‐Anne Vergilio, Hongming Zhuang, Stephanie Pitsilos, Adam Bagg, Lisa Downs, Amit K. Mehrotra, Scott Y. H. Kim, Abass Alavi, Stephen J. Schuster

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Treatment of PTLD with Rituximab or Chemotherapy

    Treatment of PTLD with Rituximab or Chemotherapy by Rebecca Elstrom, C. Andreadis, Nicole A. Aqui, Vivek N. Ahya, Roy D. Bloom, Susan C. Brozena, Kim M. Olthoff, Stephen J. Schuster, Sunita D. Nasta, Edward A. Stadtmauer, Donald E. Tsai

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma

    Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma by Jia Ruan, Peter Martin, Richard R. Furman, Shing M. Lee, Ken Cheung, Julie M. Vose, Ann S. LaCasce, J. Kaitlin Morrison, Rebecca Elstrom, Scott Ely, Amy Chadburn, Ethel Cesarman, Morton Coleman, John P. Leonard

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma

    Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma by Veronika Bachanová, Armin Ghobadi, Krish Patel, Jae H. Park, Ian W. Flinn, Prutha Shah, Carol Wong, Cara Bickers, Péter M. Szabó, Lilly Wong, Bahram Valamehr, Siminder Atwal, Yu‐Waye Chu, Rebecca Elstrom, Paolo Strati

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study

    Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study by Yuqin Song, Quanli Gao, Huilai Zhang, Lei Fan, Jianfeng Zhou, Dehui Zou, Wei Li, Haiyan Yang, Ting Liu, Quanshun Wang, Fangfang Lv, Haiyi Guo, Liudi Yang, Rebecca Elstrom, Jane Huang, William Novotny, Vivian Wei, Jun Zhu

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma

    Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma by Constantine S. Tam, Hang Quach, Andrew J. Nicol, Xavier C. Badoux, Hannah Rose, H. Miles Prince, Michael F. Leahy, Richard Eek, Nicholas Wickham, Sushrut Patil, Jane Huang, Radha Prathikanti, Aileen Cohen, Rebecca Elstrom, William Reed, Jingjing Schneider, Ian W. Flinn

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

    Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase by Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Rebecca Elstrom, Jane Huang, William Novotny, Rachel Wei, Jun Zhu

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

    Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies by Peter Martin, Amy Chadburn, Paul J. Christos, Richard R. Furman, Jia Ruan, Malea Joyce, E Fusco, Patricia Glynn, Rebecca Elstrom, Rubén Niesvizky, Eric J. Feldman, Tsiporah B. Shore, Michael W. Schuster, Scott Ely, D M Knowles, Selina Chen‐Kiang, Morton Coleman, John P. Leonard

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

    Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL by Constantine S. Tam, Judith Trotman, Stephen Opat, Jan A. Burger, Gavin Cull, David Gottlieb, Rosemary Harrup, Patrick B. Johnston, Paula Marlton, Javier Muñoz, John F. Seymour, David Simpson, Alessandra Tedeschi, Rebecca Elstrom, Yiling Yu, Zhiyu Tang, Lynn Han, Jane Huang, William Novotny, Lai Wang, Andrew W. Roberts

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma

    Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma by Thomas Clozel, ShaoNing Yang, Rebecca Elstrom, Wayne Tam, Peter Martin, Matthías Kormáksson, Samprit Banerjee, Aparna Vasanthakumar, Biljana Čuljković, David W. Scott, Sarah Wyman, Micheal Leser, Rita Shaknovich, Amy Chadburn, Fabrizio Tabbò, Lucy A. Godley, Randy D. Gascoyne, Katherine L. B. Borden, Giorgio Inghirami, John P. Leonard, Ari Melnick, Leandro Cerchietti

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma by Wyndham H. Wilson, Ryan M. Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George W. Wright, Chih-Jian Lih, P. Mickey Williams, Arthur L. Shaffer, John F. Gerecitano, Sven de Vos, André Goy, Vaishalee P. Kenkre, Paul M. Barr, Kristie A. Blum, Andrei R. Shustov, Ranjana H. Advani, Nathan Fowler, Julie M. Vose, Rebecca Elstrom, Thomas M. Habermann, Jacqueline C. Barrientos, Jesse McGreivy, Maria Fardis, Betty Chang, Fong Clow, Brian Munneke, Davina Moussa, Darrin M. Beaupre, Louis M. Staudt

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: